ZYNLONTA

ADC Therapeutics America, Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 12, 2026
Approval ID: af54af12-3edf-4301-8bc5-0446bc813c1d
Products: 1 registered
Version: 15

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ZYNLONTA safely and effectively. See full prescribing information for ZYNLONTA. ZYNLONTA (loncastuximab tesirine-lpyl) for injection, for intravenous use Initial U.S. Approval: 2021

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.